Once-monthly berobenatide in Chinese adults (Phase 3)

This is a registry record, not a result. A trial being listed, recruiting or completed says nothing by itself about whether the compound works or is safe.

Registry numberNCT07874633
StatusNot yet recruiting
PhasePhase 3
SponsorPfizer
Enrollment432 participants
DesignNot stated
ConditionsObesity; Overweight
InterventionsBerobenatide; Placebo
StartOct 15, 2026
Primary completionJun 6, 2028
Study completionNot stated
Results postedNot yet
Registry last updatedNot stated

Source: ClinicalTrials.gov (U.S. National Library of Medicine). See the trial changes feed for what has changed recently.

Share thisFacebookXEmail